Insight Molecular Diagnostics (IMDX)

• Market cap: $150M
• 1 day: -6.09%
• 5 days: -13.96%
• 1 month: -21.32%
• 3 months: 111.29%
• 6 months: 76.43%
• Year to date: 124.89%
• 1 year: 127.83%
• 5 years: -86.77%
• 10 years: -97.09%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.

Employees: 49